Edition:
United Kingdom

TherapeuticsMD Inc (TXMD.OQ)

TXMD.OQ on NASDAQ Stock Exchange Global Select Market

3.87USD
14 Dec 2018
Change (% chg)

$-0.00 (-0.00%)
Prev Close
$3.87
Open
$4.05
Day's High
$4.16
Day's Low
$3.85
Volume
672,026
Avg. Vol
621,341
52-wk High
$7.66
52-wk Low
$3.85

Chart for

About

TherapeuticsMD, Inc. is a women's healthcare company engaged in creating and commercializing products for women. The Company is focused on pursuing regulatory approvals and pre-commercialization activities necessary for commercialization of its hormone therapy pharmaceutical products. Its drug candidates used in clinical trials... (more)

Overall

Beta: 0.95
Market Cap(Mil.): $1,082.14
Shares Outstanding(Mil.): 216.43
Dividend: --
Yield (%): --

Financials

  TXMD.OQ Industry Sector
P/E (TTM): -- 31.13 34.39
EPS (TTM): -0.45 -- --
ROI: -68.00 15.55 14.96
ROE: -68.00 16.92 16.52

FDA approves TherapeuticsMD's menopause drug

The U.S. Food and Drug Administration (FDA) approved TherapeuticsMD's oral hormone therapy for menopause symptoms such as hot flashes, sleep disturbances and night sweats, the company said on Monday.

29 Oct 2018

UPDATE 1-U.S. FDA approves TherapeuticsMD's menopause drug

Oct 29 The U.S. Food and Drug Administration (FDA) approved TherapeuticsMD's oral hormone therapy for menopause symptoms such as hot flashes, sleep disturbances and night sweats, the company said on Monday.

29 Oct 2018

FDA approves TherapeuticsMD's menopause drug

Oct 29 The U.S. Food and Drug Administration approved TherapeuticsMD's oral hormone therapy for menopause symptoms such as hot flashes, sleep disturbances and night sweats, the company said on Monday.

29 Oct 2018

Earnings vs. Estimates